Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
20/20 Biolabs Inc.
20/20 Biolabs’ Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
May 27, 2026
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
May 22, 2026
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
May 20, 2026
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
May 14, 2026
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
May 12, 2026
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
May 5, 2026
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
May 3, 2026
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
April 1, 2026
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
March 11, 2026
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol “AIDX” Following 3 Consecutive Years of Sales Growth
March 11, 2026
←
Previous Page
1
2